Business

Clover Health Celebrates the Election of Dr. Ian Duncan, Clover MA Board Member, as the 2025-2026 President-Elect and Vice-Chair of the Society of Actuaries

Dr. Duncan's appointment to this prestigious role recognizes his extraordinary contributions to the actuarial profession and healthcare innovation over

articleClover Health Investments, Corp.September 18, 20254/company/clover-health-investments-corp/news/clover-health-celebrates-election-dr-ian-duncan-clover-ma-board-member-2025-2026
Clover Health Celebrates the Election of Dr. Ian Duncan, Clover MA Board Member, as the 2025-2026 President-Elect and Vice-Chair of the Society of Actuaries

About this update from Clover Health Investments, Corp.

[{"type":"text","content":"Dr. Duncan's appointment to this prestigious role recognizes his extraordinary contributions to the actuarial profession and healthcare innovation over three decades\nWILMINGTON, Del., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company dedicated to bringing access to great healthcare to everyone on Medicare, today celebrates the appointment of Dr. Ian Duncan, Ph.D., FSA, FIA, FCIA, FCA, CSPA MAAA, a member of Clover's Medicare Advantage Board of Directors, as the 2025-2026 President-Elect and Vice-Chair of the Society of Actuaries (SOA). On September 12, 2025, the SOA announced that Dr. Duncan will become the 78th President and Chair at the 2026 SOA ImpACT Annual Conference. With roots dating back to 1889, the SOA is the world’s largest actuarial professional organization, with more than 34,000 members worldwide. The SOA advances actuaries as leaders in measuring and managing risk to improve financial outcomes for individuals, organizations and the public. Clover Health has been privileged to benefit from Dr. Duncan's expertise and guidance as a member of its Medicare Advantage subsidiary’s Board of Directors. His pioneering work in predictive analytics and health risk adjustment has helped transform how the industry at large approaches value-based care, benefiting millions of patients nationwide. Dr. Duncan’s deep experience in predictive modeling and healthcare analytics continues to inform the Company's approach to improving care for Medicare beneficiaries through technology and data-driven insights. \"Congratulations to Ian on this exceptional honor,” said Andrew Toy, CEO of Clover Health. “His leadership has shaped the field of health analytics and risk adjustment for decades. This election is a win not just for actuaries, but for anyone working to build a more data-informed healthcare system.” Dr. Duncan's election to lead the Society of Actuaries comes at a time when the profession is expanding its influence across new industries and applications. His vision for modernizing actuarial education and promoting entrepreneurship within the profession has already begun to inspire a new generation of actuaries to pursue innovative career paths. “It’s an incredible honor to be elected by my peers to lead the Society o...

More updates from Clover Health Investments, Corp.